New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

HELXvsPTHETF Comparison

ETF 1
HELX

Franklin Genomic Advancements ETF

This fund is part of
BioTech & Genomics
+0.29%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-0.12%

Franklin Genomic Advancements ETF (HELX) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. HELX's top 3 sector exposures are Healthcare, Non-Energy Materials and Technology. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. HELX is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.72% for PTH. HELX is up 12.93% year-to-date (YTD) with +$6M in YTD flows. PTH performs better with 22.21% YTD performance, and +$131M in YTD flows. Run a side-by-side ETF comparison of HELX and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HELX vs PTH performance and flow charts

Performance

-2.00.02.04.06.0%Aug 11Aug 18Aug 25Sep 1Sep 9

Cumulative Flows

0 M5 M10 M15 M20 M25 MAug 11Aug 18Aug 25Sep 1Sep 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/11/2026
1M3MYTD1Y3Y5Y
Perf.
HELX
PTH
-1.05%+1.34%
+15.09%+20.02%
+12.93%+22.21%
+33.15%+52.93%
+37.37%+70.20%
-26.59%+11.54%
Flows
HELX
PTH
-+$25M
+$4M+$142M
+$6M+$131M
+$8M+$138M
+$15M+$78M
+$4M-$153M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HELX
PTH
+24.44%+27.88%
+22.84%+26.02%
+21.42%+25.99%
+23.54%+25.74%
Max drawdown
HELX
PTH
-6.59%-7.42%
-17.89%-11.91%
-29.16%-27.71%
-58.16%-49.87%
Max drawdown duration
HELX
PTH
28d40d
206d140d
458d353d
1814d1735d
Trading data

Create an account to view trading data

Join for free
HELX
PTH
Last sale
9/14/2026 at 1:30 PM
$41.56
$61.75
Previous close
09/11/2026
$40.99
$60.77
Consolidated volume
09/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HELX
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HELX
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/14/2026 at 1:30 PM
Live
Closed
HELX
PTH
Last price
$41.56
$61.75
1D performance
+1.40%
+1.61%
AuM$30.73 M$283.73 M
E/R0.5%0.72%
Characteristics
HELX
PTH
Management strategyActivePassive
ProviderFranklin TempletonInvesco
Benchmark-Dorsey Wright Healthcare Technical Leaders Index
N° of holdings6654
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateFebruary 25, 2020October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

HELX
USA
86.99%
Other
13.01%
PTH
USA
89.98%
Other
10.02%

Sectors

HELX
Healthcare
96.35%
Other
3.65%
PTH
Healthcare
99.16%
Other
0.84%

Diversification

HELX

Total weight of top 15 holdings out of 15

60.19%
PTH

Total weight of top 15 holdings out of 15

47.09%

Top 15 holdings

Data as of July 31, 2026
HELX
Guardant Health, Inc.
9.10%
Natera, Inc.
7.31%
Krystal Biotech, Inc.
6.17%
Ligand Pharmaceuticals, Inc.
4.48%
Adaptive Biotechnologies Corp.
4.33%
BridgeBio Pharma, Inc.
4.08%
United Therapeutics Corp.
3.52%
Eli Lilly & Co.
3.04%
Vertex Pharmaceuticals, Inc.
2.73%
SAMSUNG BIOLOGICS Co., Ltd.
2.72%
Travere Therapeutics, Inc.
2.67%
Corteva, Inc.
2.65%
AstraZeneca PLC
2.49%
Twist Bioscience Corp.
2.47%
Medpace Holdings, Inc.
2.44%
PTH
Roivant Sciences Ltd.
4.88%
Revolution Medicines, Inc.
4.85%
BrightSpring Health Services, Inc.
4.77%
Guardant Health, Inc.
4.50%
Axsome Therapeutics, Inc.
4.38%
Liquidia Corp.
3.17%
Erasca, Inc.
2.92%
Oruka Therapeutics, Inc.
2.54%
10X Genomics, Inc.
2.27%
Relay Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.18%
Agilon Health, Inc.
2.13%
Oscar Health, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.09%
Tango Therapeutics, Inc.
2.09%
Frequently asked questions about HELX and PTH

How have the HELX and PTH ETFs performed in 2026?

As of September 11, 2026, HELX is up 12.93% year-to-date (YTD), while PTH has returned 22.21%. That puts PTH better performer ahead so far this year.

Which ETF is attracting more investor money: HELX or PTH?

Year-to-date, the HELX ETF saw +$6M in flows, compared to +$131M for PTH.

Which ETF is more volatile: HELX or PTH?

Over the past year, HELX had a volatility of 22.84%, while PTH experienced 26.02%.

Which ETF is bigger: HELX or PTH?

As of September 11, 2026, HELX holds $30.73 M in assets under management (AUM), while PTH manages $283.73 M.

What sectors do the HELX and PTH ETFs invest in?

HELX leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.

What are the top holdings of the HELX ETF and PTH ETF?

HELX top holdings include Guardant Health, Inc., Natera, Inc. and Krystal Biotech, Inc.. PTH holds in its top three: Roivant Sciences Ltd., Revolution Medicines, Inc. and BrightSpring Health Services, Inc..

Which ETF is more diversified: HELX or PTH?

HELX holds 66 securities with 60.19% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 47.09%.

Advertisement
Latest news about HELX & PTH
Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder